"停留精巣、陰嚢水腫、包茎（小児）、鼠径ヘルニア（男児）、水腎症、膀胱尿管逆流、夜尿症 など 子供の腎臓、膀胱、外陰部の疾患の専門の診療科"

During the past decade, Dokkyo Medical University Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dokkyo Medical University Hospital" #1 sponsor was "Chugai Pharmaceutical" with 2 trials, followed by "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Chiba University" with 1 trials sponsored and "Corindus Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dokkyo Medical University Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Japan Agency for Medical Research and Development" with 1 trials as a collaborator and "Japan Blood Products Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Dokkyo Medical University Hospital" are "Sarcoma" (2 trials), "Asthma" (1 trials), "Central Neuropathic Pain" (1 trials), "Chronic Heart Failure" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Dokkyo Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Dokkyo Medical University Hospital" are "Drug" (12 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "cyclophosphamide" (2 trials), "dactinomycin" (2 trials), "vincristine sulfate" (2 trials) and "Antithrombin gamma" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dokkyo Medical University Hospital" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dokkyo Medical University Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Dokkyo Medical University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dokkyo Medical University Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Dokkyo Medical University Hospital has several departments that took part in Clinical trials: "Dokkyo University School of Medecine" - 3 trials